Purpose: The aim of this study was to analyze pre-hospital seizure rescue medication (RM) use in a pediatric epilepsy population, caregiver knowledge and comfort, and prescription patterns. Method: Cross-sectional observational study based on surveys to families of pediatric patients with epilepsy and based on medical chart review. Results: One hundred (88%) out of 114 families answered the questionnaire. Fifty-five patients were females (55%), with a median (IQR) age of 11 (6-14) years. Eighty-seven (87%) patients had RM prescribed, and 37 (42.5%) used it in the past. In univariate analysis, patients were more likely to have a RM when they had a history of SE (p < 0.001), or had seizures !30 seconds (p = 0.001). Patients were not more likely to be prescribed a RM if they were diagnosed at <2 years of age, had !3 anti-seizure medications (ASM), had a history of seizure clusters or uncontrolled epilepsy, or were currently not on ASMs. In multivariate analysis a history of SE (p = 0.02) and seizure duration !30 seconds (p = 0.04) remained significant. Out of 91 families, 68 (75%) prefer a non-rectal RM; this was higher for patients with normal development, and not associated with age or sex. Fifty-three (61%) families reported that they received RM training. Ten (12%) parents did not know the RM name, and 31 (36%) did not know the administration timing. Forty-five (45%) families had a seizure action plan (SAP), and this was a predictor for knowing the RM name (p = 0.04), the administration timing (p = 0.004), availability of RM at school (p = 0.02), and knowing what to do if the RM fails (p = 0.008). Conclusions: Most patients with epilepsy had a RM, but only 61% reported receiving training. Patients were more likely to have a RM if they had prior SE and longer seizure duration. Families with a SAP were more knowledgeable, and schools were more involved.
Introduction
The estimated prevalence of epilepsy in US children is around 1% [1] , and 22.5% of these patients are refractory to medications [2] . Status epilepticus (SE), most often defined as a seizure lasting longer than 5 minutes [3] , has an incidence of 6.8-41/100.000 per year in adults and children [4] , with an higher incidence in infants (135-156/100 000/year) [4] [5] [6] . SE has a mortality of 0-3% [5, 7, 8] , and survivors often incur developmental impairments, epilepsy, and recurrent status epilepticus [9, 10] . Seizures that last longer than 5 minutes are unlikely to stop spontaneously [11] , and prolonged seizures often become progressively more resistant to treatment [12, 13] . Therefore protocols recommend the administration of a rescue medication, consistent of a benzodiazepine (BZD), ideally between 5-10 minutes from seizure onset [14, 15] .
A study showed that the first-line treatment is often delayed in the pre-hospital and in-hospital settings. Only 37.5% of patients received anti-seizure medications (ASM) in the pre-hospital setting [16] , and a low number of patients received a rescue medication from their families, even with prior epilepsy or SE diagnosis [16] . Also, a study showed that patients who received a delayed first BZD ( > 10 minutes) had a higher risk of dying and a higher risk of receiving third-line medications to treat seizures [17] . Reasons for delayed treatment of prolonged seizures are unclear, especially in the pre-hospital setting. To address this gap in knowledge, we performed a patient family survey to evaluate the use of rescue medications in pediatric patients with epilepsy, parental knowledge, and prescription patterns.
Methods

Study design
This was a cross sectional observational study. We created a questionnaire detailing the use of rescue medications, which was reviewed by pediatric neurologists, residents and our research team (E-Supplement). We surveyed families in the outpatient setting. All patients arrived with their primary caregiver. If both parents were present both were encouraged to answer the survey jointly. We entered the results into an electronic data capture tool (RedCap), and complemented the data by clinical interviews and chart review. The prescription of rescue medications was done by the primary care providers (21 clinicians: 13 pediatric epileptologists, 5 pediatric epilepsy fellows, 3 nurse practitioners) and it was based on their clinical expertise. We aimed to enroll 100 families.
Patients
Boston Children's Hospital institutional review board approved the research protocol, and all participants, parents or guardians gave written informed consent.
Inclusion criteria consisted of: (1) children aged 0-21 years of age, (2) epilepsy diagnosis; (3) a scheduled outpatient epilepsy visit at Boston Children's Hospital, (4) English or Spanish speaker. Exclusion criteria were: (1) psychogenic non-epileptic seizures; (2) infantile spasms; and (3) electrical status epilepticus in sleep.
Variables
The primary outcome was the prescription of rescue medication in patients with epilepsy. The secondary outcome was the parental level of knowledge about rescue medications. We also looked at other tertiary outcomes: training, availability of an individualized seizure action plan (a plan that guides families, caregivers and schools in case of a seizure, it provides information regarding rescue medication administration, timing, and rescue measures), medication route preferences, medical history, number of ASM, parental report of school involvement, doses, and cost limitation. The training was done during regular clinical practice, and it was evaluated retrospectively.
We compared the recommended weight based dose to the medication doses of the most recent prescription. For rectal diazepam, we used 0.5 mg/kg for age 2-5 years, 0.3 mg/kg for age 6-11 years and 0.2 mg/kg for age 12 years or older, [18] which were rounded to 5, 10, 15 and 20 mg, with a 20 mg maximum, as these are the doses commonly available. [19] For nasal midazolam, we used 0.2 mg/kg with a 10 mg maximum [20, 21] , and 0.05 mg/kg for oral lorazepam, with 4 mg maximum [22] , and we rounded the dose to the closest unit (ie. 2 mg, 4 mg) to calculate if the dose was low, appropriate, or high.
Statistical analysis
We used descriptive statistics to summarize demographic and clinical characteristics. The evaluation of most variables did not fit a normal distribution; therefore we utilized non-parametric analyses. We expressed continuous variables as median and inter-quartile range (IQR). We analyzed binary outcome variables with Fisher exact test. To determine predictors for receiving a rescue medication we first performed univariate analysis with Fisher's exact test. We created a model with the variables: seizure duration >30 sec (median seizure duration time), history of SE, history of seizure cluster, epilepsy diagnosis < 2 years of age (as rescue medications <2 years are not FDA approved), uncontrolled epilepsy, currently on ASM and 3 or more ASMs. To build the multivariate model we selected the variables with a p-value <0.1. As some bins had zero counts, we performed an exact logistic regression analysis. To evaluate the association of non-rectal route medication application preference to developmental status, age and sex we used logistic regression. We set the two-sided alpha value at 0.05. All statistical analyses were performed with STATA 13 (Stata Corp., College Station, TX).
Results
Patients
We approached 114 families of patients with epilepsy. Five (4.4%) met exclusion criteria, 9 (7.9%) families elected not to fill out the survey due to time constraint, and 100 (87.7%) families participated. Demographics and clinical features are summarized in Table 1 .
Rescue Medications
Out of 100 patients with epilepsy, 87 had seizure rescue medications prescribed (Fig. 1) . The prescription range was 90% in children age 0-7 years, 86% in 7-14 years, and 83% in 14-21 years. Thirty-seven (42.5%) patients with a prescribed rescue medication had used it in the past and the median (p25-p75) amount of times they used the rescue medication was 4 (2-8). Twelve (32.4%) parents reported the recue medication was always successful stopping the seizures, 16 (43.2%) said it was successful more than 50% of the time, 4 (10.8%) less than 50% of the time, and 3 (8.1%) said it was never successful. Out of these patients, 24 (64.8%) used it for prolonged seizures (! 5 minutes) and 12 (32.4%) for seizure clusters. Families who used the rescue medication for seizure clusters, administered it after a median (p25-p75) of 4 (3-5) seizures. Legend: Race and ethnicity was obtained from the family's demographic information form within the electronic medical record. Some patients prefer to not report their race, and some report it as 'unknown' or not represented with those categories.
Predictors for rescue medications
In univariate analyses, patients were more likely to have a rescue medication prescribed if seizures were on average longer than 30 seconds (p = 0.001), and if they had a history of status epilepticus ( p< 0.001) ( Table 2 ). There was no difference in the percentage of rescue medication prescriptions among patients with and without a history of seizure clusters, more than 3 ASM, patients diagnosed with epilepsy onset before and after 2 years of age, seizure control or lack thereof with medication treatment, and between patients who were or were not currently treated with ASMs (Table 2) . In multivariate analysis, a history of SE (p = 0.02) and an average seizure duration longer than 30 seconds (p = 0.04) remained significant (Table 2) .
Dose and medication application route
The rescue medication dose indicated in the most recent visit was in a recommended range in 35 (40.7%) patients, low in 44 (51.2%) patients and high in 7 (8.14%) patients according to routinely accepted benzodiazepine dosing. Table 3 depicts rescue medication prescriptions and time to administration indication. Out of 91 families, 68 (74.7%) said that they would prefer a nonrectal rescue medication if it had the same efficacy ( Fig. 1 ). This preference increased to 89.8% in families of a child with normal development as compared to 63.5% of families of a child with developmental delay (OR 5.32, 95%CI 1.61-17.63; p = 0.004). Fiftyfive patients had developmental delay, and 28 (51%) were female. Medication route application preference was not related to age (non-rectal route had a median age 11 (6.5-14.5) vs rectal route: 11 (5-13) years; p = 0.5) or sex (non-rectal route: 51% females vs rectal route: 61% females, p = 0.3).
Rescue medications availability
Two (2.3%) families with prescribed rescue medication indicated that they did not have rescue medication available at home, and 14 (16.1%) shared that they did not have rescue medication available outside the home. Four (4.6%) out of 87 patients mentioned that the cost of rescue medication was a limitation. Out of 67 families, 62 (92.5%) said that there was someone else who knew how to use of the rescue medication, while 5 (7.5%) said nobody else knew. The most common answers were close family (42 (67.7%)), school nurses or teachers (40 (64.5%)), and others such as close friends, bus driver, or other health care members (5 (8.1%)). Out of 100 patients with epilepsy, 13 did not have a rescue medication prescribed. Out of 91 families, 68 (74.7%) said that they would prefer a non-rectal rescue medication, and this preference was related to the developmental status (p = 0.006) and not to age (p = 0.5) or sex (p = 0.3). 
Level of parental knowledge
Out of the 87 patients with a prescribed rescue medication, 10 (11.5%) did not know the name of the medication. Thirty-one (35.6%) parents either did not know after how many minutes they should administer the rescue medication, or they provided a different time interval than the one on the prescription. We asked parents what they would do if the rescue medication does not stop seizures. Forty-two (48.3%) parents said they would call 911, 6 (6.9%) said they would go to the emergency room, 3 (3.5%) said they would call their neurologist, 1 (1.2%) would try additional treatment (vagus nerve stimulation), 8 (9.2%) said they did not know and 27 (31.0%) left the answer blank.
Seizure action plan
Forty-five (45%) parents recalled having a seizure action plan, while 55 (55%) conveyed that they did not have a seizure action plan or were unsure about it. Parents who recalled that they had a seizure action plan knew the name of the medication (42 (93.3%) vs 33 (60.0%); p = 0.04), and the timing to administration of the medication more often than parents who did not have a seizure action plan (35 (77.8%) vs 20 (36.4%); p = 0.004) (Fig. 2) . Parents with a seizure action plan also answered more frequently that they would take action -either call 911, their neurologist or go to the ERif the rescue medication did not work than parents with no seizure action plan (68.9% vs 40.8%; p = 0.008) (Fig. 2) . Out of the patients who have a rescue medication, 80 (92%) were attending school or an educational facility, with a median (IQR) duration of 6.5 (6-7) hours per day. Sixty-seven (83.8%) families (out of 80 families with rescue medication who answered this question) reported that the school was aware of the rescue medication; this was higher in the group of patients with a seizure action plan (97.7% vs 56.8%; p < 0.001). Fourteen out of 80 (17.5%) families reported that the school does not have access to the rescue medication. A rescue medication was also more frequently available at school when families had a seizure action plan (88.4% vs 66.7%; p = 0.02) (Fig. 2) .
Training
Out of all patients with a prescribed rescue medication, 53 (60.9%) reported that they received training on how to administer the drug. Seventy-nine percent of families reported training when their children were between 0-7 years of age, 58% in 7-14 year olds, and 40% in 14-21 year olds. These patients scored the quality of training with a median (IQR) 10 (8-10) out of 10. Parents rated the training with a median 10 (9-10) when it was done by a Neurologist, and with a median 9 (8-10) when it was done by other medical staff (p = 0.057). Parents had the option of suggesting improvements and they indicated that they would like a more hands-on training experience, refreshers after a few years of the initial training, and seizure action plans or educational materials to provide to the school and other family members.
Discussion
Most patients with epilepsy had a rescue medication prescribed, and the main predictor for having a rescue medication was a history of status epilepticus and average seizure duration > 30 seconds. Only 61% of families reported receiving training on rescue medication use. A third of families did not know the recommended time interval for administration. The parental level of knowledge and school involvement was better when they had an individualized seizure action plan.
Use of rescue medications
Patients with a diagnosis of epilepsy may require availability of rescue medication at home, especially those at risk of prolonged seizures [23] . A study of 81 children with refractory status epilepticus showed that only 37.5% of patients received rescue medications in the pre-hospital setting, and the treatment was commonly delayed [17] . Out of the patients who received pre-hospital treatment, 7 out of 12 patients with prior epilepsy diagnosis received a rescue medication from their families [17] . In a different series of 73 children, 41% received a rescue medication from emergency medical services, but only 1% from families [24] . A study of 189 children with refractory status epilepticus showed that the timing to the first benzodiazepine was similar in patients with and without prior history of epilepsy [25] . A study including 93 status epilepticus episodes in children showed that only 37% received rescue medication from family members although 72.9% had a prior history of status epilepticus [26] . This low percentage of rescue medication use by families in some of these studies may be explained by a low prescription frequency of rescue medication, insufficient training, or lack of school involvement, among others, and our survey attempted to elucidate these factors in more detail. In our study, 87% of patients with epilepsy had a rescue medication prescription. However, only 61% of them received training. Families who reported having a seizure action had a higher likelihood of knowing the name of the medication (p = 0.04), the timing of the medication (p = 0.004), and answered more frequently that they would take action (p = 0.008). Families with a SAP also reported higher school awareness (p < 0.001) and a higher availability of the rescue medication in the schools (p = 0.02). These data suggest that seizure action plans should be a part of prescribing rescue medications. Legend: SAP: Seizure Action Plan. RM: rescue medication.
Rescue medications in the pre-hospital setting
Most seizures start in the pre-hospital setting [27] and if a rescue medication is not available, the treatment will start once the emergency medical services arrive, or once the patient arrives to the hospital, which rarely happens prior to the 10 minute seizure onset mark. Several studies have shown that the timing of the treatment is associated with prolonged duration of seizures [17, 28, 29] use of continuous infusions and mortality [17] . Prehospital treatment may shorten status epilepticus duration [30, 31] , and may improve outcomes, such as decrease in recurrent seizures [31] , emergency calls, emergency department visits and hospital admissions, and improved quality of life [32] . The fastest option for pre-hospital treatment are the care providers, often the families. Different guidelines recommend administering rescue medications between 5 to 10 minutes from seizure onset, [33, 34] or even before 5 minutes [15] , and in our study most prescriptions varied between 3 to 5 mintues (Table 3) , and 10% also included seizure clusters.
Predictors for rescue medications
Previous studies regarding the use of rescue medication (based on providers or caregivers) focused on the population who had rescue medications prescribed [32, [35] [36] [37] [38] . We studied the overall population with epilepsy at the outpatient epilepsy clinic and found that 87% of patients had a rescue medication. A survey to 190 families of patients with a prescribed rescue medication showed that children with epilepsy but also history of prolonged seizures were the ones who usually have a rescue medication [35] . In our study, the main predictors for having a rescue medication prescription were a previous history of status epilepticus and seizures longer than 30 seconds on average. It is reasonable that patients with a history of status epilepticus should have a rescue medication at home. Furthermore, patients with epilepsy who have seizure clusters, for example, could evolve into status epilepticus, and based on these results, they may not have a rescue medication at the first status epilepticus episode. Twelve families in our study used a rescue medication for seizure clusters previously. Nine prescriptions included seizure clusters in the indications.
One reason for not prescribing a rescue medication to the overall epilepsy population could be the fear of adverse effects such as respiratory depression. Major adverse effects, however, usually occur and increase only after the administration of more than two doses of benzodiazepines [26, 39] , suggesting that at least one dose can be given safely in most patients. Also, a multicenter prospective study showed that patients with prolonged seizures had higher risk of respiratory depression when receiving a placebo versus a benzodiazepine in the prehospital setting [27] . Additionally, respiratory arrest or apnea may be related to sudden unexpected death in epilepsy (SUDEP) [40] [41] [42] . If usage of prompt and adequately dosed rescue medications reduces respiratory depression, this may also play a factor in preventing further complications.
Rescue Medication Doses
The dose of the medication may also impact its efficacy to stop seizures. A study that compared 3 different first line benzodiazepines (lorazepam, clonazepam and midazolam) in adults reported a 41% rate of low doses, and showed that a low dose of lorazepam was associated to a higher percentage of patients with refractory status epilepticus but not in clonazepam and midazolam [43] . Other studies also report low doses in the first line treatment [30, 44] . In our study, several patients had a lower (51.2%) or higher (8.1%) dose than the recommendation. The large percentage of low doses may be related to the fast changes in weight in children, availability of specific dosing, and possibly concerns regarding overdosing or respiratory complications in the pre-hospital setting. Based on this survey, we have now implemented quality improvement measures to update dosing in all patients in our clinics routinely and regularly.
Medication application routes
First line benzodiazepines are available in different routes of administration, depending on the drug. A study reported that 24 families had both nasal or buccal midazolam as well as rectal diazepam. Twenty (83%) of these families preferred the non-rectal route of administration [38] . Our study is concordant with these results as 75% said that they would prefer a non-rectal rescue medication if the efficacy was the same. This preference was associated to the developmental status of the children and not the age or sex. However, most patients in our study had rectal rescue medications; the only rescue mediaction that is currently approved by the FDA in the USA is rectal diazepam, and this may change when different options get approval. There appears to be a need for additional routes of administration that are fast, easy to administer and socially accepted.
Training
The use of a rescue medication likely also depends on caregiver knowledge and understanding of use. In a survey of 190 families with a prescribed rescue medication, 90% recalled receiving training about the rescue medication [35] . In our study, 61% of the families recalled receiving training. The training was administered by different staff, and the score tended to be better when patients and families were trained by a neurologist. Also, the reported training frequency declined with age (79% in 0-7 years, 58% in 7-14 years, 40% in 14-21 year old patients). It is unclear if this is recall or selection bias for training.
Seizure action plan and level of knowledge
A rescue medication prescription may require a clear and individualized seizure action plan that guides families and schools in case of a seizure. A study including 190 families and 203 pediatricians showed that 89% of pediatricians and 79% of families reported having a seizure action plan for the use of a rescue medication in the community [35] . We found a lower percentage of seizure action plan (45%) based on the family reports. As in the other study, the percentage reported by their physicians may be higher. However, if families do not remember having a seizure action plan, they are likely not actively using it.
We also analyzed the level of knowledge of the families who had a rescue medication: 12% did not know the name of the medication, and 36% did not know the recommended time to administration. Having a seizure action plan was associated with better level of knowledge and increased school involvement. Families also knew better what to do if the rescue medication did not stop the seizure when they had a seizure action plan. There is a need for educational interventions and standardized trainings for families who have rescue medications.
Rescue medications availability
Even if patients have been prescribed a rescue medication, this does not necessarily mean that it is always available. In our study 2.3% of patients with a prescribed rescue medication did not have the rescue medication at home, and 16% did not carry it outside the home. Most patients attend a school or other type of facilities during the day. A child may receive a rescue medication at school depending on different legal aspects and depending on availability of a school nurse. There may be room for improvement in the care of patients with epilepsy at schools [22, 34, 44] . A survey of 185 teachers in England showed that 37.7% of schools have a written epilepsy policy and 25.8% of teachers had not had epilepsy training during the last three years [45] . In our study families reported that 83.8% of schools were aware of the rescue medication, but 17.5% of the schools did not have access to it. Cost of the medication may also be a limiting factor [46] ; but only 4.6% of the families in our study reported that cost was a limitation, as the drug was often covered by their insurances. However, this could vary largely depending on the state or country.
Strengths and limitations
This was a cross-sectional survey and data have been corroborated by medical chart review in an outpatient epilepsy population. We used a survey to elicit a caregiver perspective on rescue medications. Limitations may include that families may not remember all information that was provided and there could be a recall bias for some of the variables. However, if families do not remember, for example, that they received training when they actually did, this is likely still an indicator of their knowledge and uncertainty about rescue medication use. Also, the information was obtained from the primary caregiver only. In follow up studies, we intend to work with an online tool (Trivox [47] ), which will allow for additional identification of care giver, including other stake holders, such as teachers. Prescriptions were initially monitored by clinicians, but as a result of this survey they are now routinely checked, adjusted and updated by nursing team members in the outpatient setting prior to the visit, and given to the prescribing physician for signature. A strength of this study is that we also evaluated the population who did not have a rescue medication, and this helped us to better understand why some patients are prescribed a rescue medication and others are not. We included English and Spanish speakers. We also asked families for feedback in terms of training, and this will help us develop better educational interventions based on caregiver perspectives, with ongoing patient and family input.
Conclusions
Most patients with epilepsy had a rescue medication, but only 61% reported receiving training on how to administer the medication. Patients were more likely to have a rescue medication if they had prior status epilepticus or seizures lasting longer than 30 seconds. Families with a seizure action plan were more knowledgeable and schools were more involved. Educational interventions may improve families' knowledge and use of rescue medication in the pre-hospital setting.
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